InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.25
(
-0.14%
)
US TECH 100
17,597.00
(
-0.09%
)
Dow Jones
38,943.44
(
0.15%
)
Brent Oil
83.31
(
0.54%
)
Bitcoin
62,313.72
(
-0.03%
)
Post# of 7269
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

devilskyvin

Send PM Follow Ignore
Followers 16
Posts 530
Boards Moderated 0
Alias Born 12/27/2013

devilskyvin

Re: None

Friday, 10/21/2016 8:21:59 AM

Friday, October 21, 2016 8:21:59 AM

Post# of 7269
Zynerba Provides Clinical Update for Lead Development Candidates – ZYN001 and ZYN002
By GlobeNewswire, October 17, 2016, 07:00:00 AM EDT
Vote upAAA



Phase 1 clinical trial for ZYN001 is expected to begin in 1H17



Read more: http://www.nasdaq.com/press-release/zynerba-provides-clinical-update-for-lead-development--candidates--zyn001-and-zyn002-20161017-00151#ixzz4Nio5mdND
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up